ArticleFrontiers in immunology2022

Case report: A case of duodenal adenocarcinoma achieving significantly long survival treating with immune checkpoint inhibitors and chemotherapy without positive biomarkers.

Xian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.